How Penn Medicine is changing the world with mRNA nocred How Penn Medicine is changing the world with mRNA Vaccines are just the beginning of the potential for messenger RNA, the Nobel Prize-winning technology.
Microrobots: An emerging biomedical trend Image: Courtesy of iStock / K_E_N Q&A Microrobots: An emerging biomedical trend In a Q&A with Penn Today, Hyun (Michel) Koo of the School of Dental Medicine and Edward Steager of the School of Engineering and Applied Science discuss the emerging trend of microrobots in healthcare.
Exchanging climate knowledge at COP28 Image: Dominika Zarzycka/NurPhoto via AP Exchanging climate knowledge at COP28 More than two dozen researchers from schools and centers across the University traveled to Dubai for the UN’s annual climate change conference.
Celebrating innovation and impact During its recent eighth annual Celebration of Innovation, the Penn Center for Innovation (PCI) reported on a successful fiscal year 2023. From left: Sean McCooe, Holger Kissel, Shu Yang, Firooz Alfatouni, Steve Kelly, and Sean Marett. (Image: Courtesy of Felice Macera) Celebrating innovation and impact Now in its tenth year of operation, the Penn Center for Innovation marked innovation achievements from fiscal year 2023 with highlights and awards.
Things to know: E-scooters and safety With the rising popularity of e-scooters, the Division of Public Safety is spreading the message of safe use and operation of these devices that are prohibited from campus buildings. (Image: iStock / panom73) Things to know: E-scooters and safety Penn’s Gene Janda and Joe Romm and Andrew Baldwin of the Philadelphia Fire Department discuss lithium-ion battery fire risks.
Penn gathers at COP28 to share ideas and research in university pavilion Image: Kalawin/iStock Penn gathers at COP28 to share ideas and research in university pavilion A delegation of University researchers will be providing expertise on a wide array of issues to be discussed at COP28, the annual climate conference of the United Nations.
Study shows promise for iNKT cell platform to treat cancer Canine iNKT cells (Image: Courtesy of Nicola Mason and Antonia Rotolo) Study shows promise for iNKT cell platform to treat cancer Researchers from the School of Veterinary Medicine and Perelman School of Medicine have shown that invariant natural killer T cells from a healthy donor can persist in MHC-mismatched canines, demonstrating a reliable platform to inform human clinical trials.
The crisis of climate-driven extinction From left: Erol Akçay, associate professor of biology in the School of Arts & Sciences; Michael Mann, Presidential Distinguished Professor in the Department of Earth and Environmental Science in the School of Arts & Sciences, with a secondary appointment in the Annenberg School for Communication; Zinta Zommers, humanitarian affairs officer with the United Nations Office for the Coordination of Humanitarian Affairs and served as the Wolk Visiting Fellow (2021-22) and a Visiting Fellow (2022-23) at the Perry World House; and Simon Richter, professor of Germanic languages and literatures, a Perry World House faculty fellow, a faculty fellow of Penn Institute of Urban Research, and a faculty advisory board member of the Water Center at Penn. (Image: Courtesy of Gabrielle Szcepanek) The crisis of climate-driven extinction In a session moderated by Simon Richter, panelists Erol Akçay, Michael Mann, and Zinta Zommers discussed the impact of climate change on efforts to conserve biological diversity.
Removing the barrier surrounding solid tumors clears path for T cells Stroma-targeting CAR T cells (green) accumulate in the stroma surrounding a tumor in a mouse model of pancreatic cancer. (Image: Zebin Xiao) Removing the barrier surrounding solid tumors clears path for T cells Penn researchers uncover a new way to target solid tumors. Using CAR T cells to remove cancer-associated fibroblasts surrounding pancreatic tumors allows T cells to infiltrate and attack the tumor cells.
Genetic switch turns tumor suppressor into oncogene in colorectal cancer (Image: Yuhua Tian) Genetic switch turns tumor suppressor into oncogene in colorectal cancer Researchers from the School of Veterinary Medicine have shown that an enzyme that suppresses early-stage colorectal cancer switches to become an oncogene as the cancer progresses.